We are live on
!
Find out more
Lord, Abbett & Co Portfolio holdings
AUM
$30.6B
1-Year Est. Return
57.44%
This Fund
S&P 500
This Quarter
Est. Return
+7.35%
1 Year Est. Return
+57.44%
3 Year Est. Return
+215.76%
5 Year Est. Return
+368.6%
10 Year Est. Return
+2,376.62%
AUM
$34.2B
AUM Growth
+$542M
(+1.6%)
Cap. Flow
-$1.99B
Cap. Flow
% of AUM
-5.81%
Top 10 Holdings %
Top 10 Hldgs %
9.11%
Holding
929
New
105
Increased
255
Reduced
383
Closed
91
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Merck
MRK
|
+$140M |
| 2 |
Invesco Senior Loan ETF
BKLN
|
+$115M |
| 3 |
GWPH
GW Pharmaceuticals Plc American Depositary Shares
GWPH
|
+$110M |
| 4 |
Meta Platforms (Facebook)
META
|
+$104M |
| 5 |
Evergy
EVRG
|
+$85.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Lowe's Companies
LOW
|
+$98.1M |
| 2 |
Floor & Decor
FND
|
+$86.6M |
| 3 |
Live Nation Entertainment
LYV
|
+$84.6M |
| 4 |
Diamondback Energy
FANG
|
+$84.3M |
| 5 |
RenaissanceRe
RNR
|
+$84M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 14.96% |
| 2 | Healthcare | 14.76% |
| 3 | Technology | 14.39% |
| 4 | Industrials | 11.44% |
| 5 | Consumer Discretionary | 10.08% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
151
CVS Health
CVS
$137B
| $69.5M | 0.2% |
1,079,700
+187,500
| +21% | +$12.4M |
|
|
HOME
152
DELISTED
At Home Group Inc.
HOME
| $69.5M | 0.2% |
1,774,410
+232,759
| +15% | +$8.35M |
|
153
Icon
ICLR
$12.8B
| $69.4M | 0.2% |
523,739
+58,206
| +13% | +$7.26M |
|
154
Lockheed Martin
LMT
$134B
| $69.1M | 0.2% |
233,753
-116,403
| -33% | -$37.5M |
|
155
PepsiCo
PEP
$186B
| $68.7M | 0.2% |
630,585
-87,626
| -12% | -$9.05M |
|
156
MSCI
MSCI
$40B
| $68.1M | 0.2% |
411,513
-112,010
| -21% | -$17.7M |
|
|
NEWR
157
DELISTED
New Relic, Inc.
NEWR
| $68M | 0.2% |
676,282
+418,141
| +162% | +$37.1M |
|
158
American Water Works
AWK
$26.3B
| $67.9M | 0.2% |
795,035
+232,436
| +41% | +$19.2M |
|
159
Eagle Materials
EXP
$6.6B
| $67.8M | 0.2% |
645,912
-125,074
| -16% | -$13.2M |
|
160
Roku
ROKU
$21.1B
| $67.5M | 0.2% |
1,583,238
+1,293,826
| +447% | +$47.2M |
|
161
Boston Properties
BXP
$11B
| $67.4M | 0.2% |
537,335
-17,943
| -3% | -$2.18M |
|
162
CSX Corp
CSX
$98.6B
| $67.2M | 0.2% |
3,159,810
+508,797
| +19% | +$10.5M |
|
163
Texas Roadhouse
TXRH
$12.7B
| $67.1M | 0.2% |
1,024,303
+216,774
| +27% | +$13.6M |
|
164
Spotify
SPOT
$99.2B
| $67M | 0.2% |
+398,000
| New | +$63.6M |
|
165
Amgen
AMGN
$203B
| $66.5M | 0.19% |
360,300
+55,800
| +18% | +$9.87M |
|
166
Veeva Systems
VEEV
$30.3B
| $66.1M | 0.19% |
860,110
+556,612
| +183% | +$42.3M |
|
167
Boston Scientific
BSX
$65.8B
| $66M | 0.19% |
+2,019,295
| New | +$60.9M |
|
168
TJX Companies
TJX
$170B
| $65.8M | 0.19% |
1,382,902
+271,214
| +24% | +$11.9M |
|
169
HealthEquity
HQY
$7.91B
| $65.7M | 0.19% |
874,687
+626,309
| +252% | +$45M |
|
170
EOG Resources
EOG
$78B
| $65.6M | 0.19% |
527,418
-55,973
| -10% | -$6.5M |
|
|
STMP
171
DELISTED
Stamps.com, Inc.
STMP
| $65.5M | 0.19% |
258,867
+132,260
| +104% | +$31.9M |
|
172
Celanese
CE
$5.09B
| $65.1M | 0.19% |
585,900
+9,800
| +2% | +$1.08M |
|
173
Essex Property Trust
ESS
$18.9B
| $64.6M | 0.19% |
270,400
+109,600
| +68% | +$26.1M |
|
|
MIME
174
DELISTED
Mimecast Limited
MIME
| $64.6M | 0.19% |
1,568,164
+610,019
| +64% | +$24.8M |
|
175
Exelon
EXC
$48.6B
| $64.2M | 0.19% |
2,112,954
-382,466
| -15% | -$11M |
|
Similar funds
Lord, Abbett & Co's Q2 2018 Portfolio in Review
As of Q2 2018, Lord, Abbett & Co held 929 positions worth $34.2B, up 1.6% from $33.7B the previous quarter. Its ten largest holdings account for 9.1% of the portfolio.
Lord, Abbett & Co withdrew a net $1.99B in Q2 2018, closing 91 positions and reducing 383 holdings. Its most notable exit was Floor & Decor, an estimated $86.6M position sold in full.
By sector, the portfolio is most concentrated in Financials at 15% of assets, down from 17% a quarter earlier, followed by Healthcare and Technology.
Against the trend, Lord, Abbett & Co opened a new position in GW Pharmaceuticals Plc American Depositary Shares worth $108M.
- Lord, Abbett & Co's largest Q2 2018 buy was GW Pharmaceuticals Plc American Depositary Shares: 771,206 shares worth $108M.
- Lord, Abbett & Co added most to Merck in Q2 2018, an estimated $140M increase.
- Lord, Abbett & Co's biggest Q2 2018 reduction was Lowe's Companies, cutting an estimated $98.1M.
- Lord, Abbett & Co fully exited Floor & Decor in Q2 2018, selling an estimated $86.6M.
- Lord, Abbett & Co's ten largest holdings make up 9.1% of its $34.2B portfolio in Q2 2018.
- Lord, Abbett & Co opened 105 new positions and closed 91 in Q2 2018.
- Lord, Abbett & Co's portfolio value rose 1.6% quarter-over-quarter to $34.2B.
Based on Lord, Abbett & Co's 13F filing for Q2 2018, filed 14 Aug 2018.